Replication of modified vaccinia virus Ankara in primary chicken embryo fibroblasts requires expression of the interferon resistance gene E3L.
about
Poxvirus tropismGeneration of a complete single-gene knockout bacterial artificial chromosome library of cowpox virus and identification of its essential genesCross-protective immunity against multiple influenza virus subtypes by a novel modified vaccinia Ankara (MVA) vectored vaccine in mice.Efficacy and safety of a modified vaccinia Ankara (MVA) vectored plague vaccine in mice.Rapid expansion of CD8+ T cells in wild-type and type I interferon receptor-deficient mice correlates with protection after low-dose emergency immunization with modified vaccinia virus Ankara.Cellular and biochemical differences between two attenuated poxvirus vaccine candidates (MVA and NYVAC) and role of the C7L gene.A poxvirus host range protein, CP77, binds to a cellular protein, HMG20A, and regulates its dissociation from the vaccinia virus genome in CHO-K1 cellsDeletion of Fifteen Open Reading Frames from Modified Vaccinia Virus Ankara Fails to Improve ImmunogenicitySelection of recombinant MVA by rescue of the essential D4R gene.Direct comparison of antigen production and induction of apoptosis by canarypox virus- and modified vaccinia virus ankara-human immunodeficiency virus vaccine vectorsDistinct gene expression profiling after infection of immature human monocyte-derived dendritic cells by the attenuated poxvirus vectors MVA and NYVAC.HIV-1 accessory proteins VPR and Vif modulate antiviral response by targeting IRF-3 for degradationVaccinia virus subverts a mitochondrial antiviral signaling protein-dependent innate immune response in keratinocytes through its double-stranded RNA binding protein, E3.The orthopoxvirus 68-kilodalton ankyrin-like protein is essential for DNA replication and complete gene expression of modified vaccinia virus Ankara in nonpermissive human and murine cells.Dendritic cell subtypes as primary targets of vaccines: the emerging role and cross-talk of pattern recognition receptors.Recent advances in antibody-inducing poxviral and adenoviral vectored vaccine delivery platforms for difficult disease targets.Role of viral factor E3L in modified vaccinia virus ankara infection of human HeLa Cells: regulation of the virus life cycle and identification of differentially expressed host genes.The cellular antiviral restriction factor tetherin does not inhibit poxviral replicationInduction of apoptosis limits cytomegalovirus cross-species infection.Vaccinia virus-mediated inhibition of type I interferon responses is a multifactorial process involving the soluble type I interferon receptor B18 and intracellular componentsModified vaccinia virus Ankara protein F1L is a novel BH3-domain-binding protein and acts together with the early viral protein E3L to block virus-associated apoptosis.E3L and F1L Gene Functions Modulate the Protective Capacity of Modified Vaccinia Virus Ankara Immunization in Murine Model of Human Smallpox.Ectromelia virus lacking the E3L ortholog is replication-defective and nonpathogenic but does induce protective immunity in a mouse strain susceptible to lethal mousepox.A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA.
P2860
Q28237434-7548041E-BEA3-4F58-A4F1-2F820E708F84Q28659589-A14875CF-CDDD-4718-943F-7C0B35CC3A3BQ30426730-662705C5-1F04-4FDB-8C07-46BABE378825Q33635050-05D255FB-B142-4BC4-BED8-F8C36FB0CA7CQ34262138-1E398CE0-D292-49C8-BBDE-B550C13B87FAQ34651266-35DF09AC-D209-4254-AE00-9DEE46111799Q35023806-703B6D8A-0214-4221-B800-A2D18DFBE5AFQ35656345-230C6277-91AE-4B20-A43C-D7F12CD88E65Q35800430-F856B9C4-2695-4DD1-AE49-6DEBEEFB55ABQ35914427-2426774A-EA4B-48C6-9D60-11BF5D865C25Q35947683-34E015F7-A8E3-4298-859A-CC3FC7C1F089Q36559594-08E118CC-7B1D-4821-A2D3-CF712315D707Q36949602-008A7F83-7352-4669-80C8-D54370171F17Q37204575-4B25F6D2-B8A3-4A8B-AD64-F31D28F0912BQ37309247-D7A5474D-E8D4-44F7-BEE1-66E28035C266Q38096489-4D3E9A98-0F0C-42CB-BDCC-A8D24B3E1A17Q38331191-898B5628-046A-494A-B555-FF115B7AC7D6Q39441885-7FE9D777-ACB0-4411-9767-B7A80B0DB461Q40281364-B07BA384-1D28-46D7-B533-0CD42E0CCE27Q42093151-A12EFCED-AA0A-4911-A82B-82A04EBF09C3Q45437312-E47EA710-444C-42F6-AB8A-3A9D5508DE5DQ47233214-590A3027-5B17-4EAF-BD5F-875BB323A109Q52690434-A3914E30-F022-4792-A5E1-FFEBD285BE35Q54631516-B11CE7C7-7AF4-4EC8-8851-D135E43CDA82
P2860
Replication of modified vaccinia virus Ankara in primary chicken embryo fibroblasts requires expression of the interferon resistance gene E3L.
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Replication of modified vaccin ...... nterferon resistance gene E3L.
@ast
Replication of modified vaccin ...... nterferon resistance gene E3L.
@en
type
label
Replication of modified vaccin ...... nterferon resistance gene E3L.
@ast
Replication of modified vaccin ...... nterferon resistance gene E3L.
@en
prefLabel
Replication of modified vaccin ...... nterferon resistance gene E3L.
@ast
Replication of modified vaccin ...... nterferon resistance gene E3L.
@en
P2093
P2860
P1433
P1476
Replication of modified vaccin ...... nterferon resistance gene E3L.
@en
P2093
Bernd Kaspers
Caroline Staib
Georg Häcker
Gerd Sutter
Olof Harlin
Sigrid Kisling
Volker Erfle
P2860
P304
P356
10.1128/JVI.77.15.8394-8407.2003
P577
2003-08-01T00:00:00Z